Vivos therapeutics schedules release of second quarter 2023 financial results and conference call

Littleton, colo., aug. 10, 2023 (globe newswire) -- vivos therapeutics, inc. (“vivos” or the “company'') (nasdaq: vvos), a medical technology company focused on developing and commercializing innovative diagnostic and treatment methods for patients suffering from a variety of health conditions, many of which are associated with breathing related sleep issues arising from certain dentofacial abnormalities, today announced it plans to release its second quarter 2023 financial results after market close on monday, august 14, 2023.
VVOS Ratings Summary
VVOS Quant Ranking